REQUEST A DEMO
Total
USD $0.00
Search more companies

Gdi Pharma S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Gdi Pharma S.A.S. Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Gdi Pharma S.A.S. is an enterprise in Colombia, with the main office in Bogota D.C.. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on October 01, 2018. It currently has a total number of 15 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 39.69% in 2023. A negative growth of 12% was recorded in its total assets.

Headquarters
Cl 66 68 B 59
Bogota D.C.; Bogota D.C; Postal Code: 0902

Contact Details: Purchase the Gdi Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Gdi Pharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Gdi Pharma S.A.S. report to view the information.
Incorporation Date:
October 01, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Gdi Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
39.69%
Total operating revenue
39.69%
Operating profit (EBIT)
125.34%
Total assets
-12%
Total equity
12.13%
Operating Profit Margin (ROS)
2.78%
Quick Ratio
-1.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?